P-BCMA-101 Tscm CAR-T cells

P-BCMA-101 Tscm CAR-T cells · Poseida Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P-BCMA-101 Tscm CAR-T cells, covering 2023-06-22 to 2023-06-22. Get the full timeline:

Most recent: Clinical Trial Update: P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) [Phase 1, Phase 2]